Novocure (NVCR) Secures $400M Multi-Tranche Non-Dilutive Debt Financing

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. TSLA
6. ISRG
7. SMCI
8. RTX
9. GOOGL
10. S

Go back to Novocure (NVCR) Secures $400M Multi-Tranche Non-Dilutive Debt Financing

NovoCure Ltd. (NVCR) PT Lowered to $14.50 at Evercore ISI

May 2, 2024 4:48 PM EDT

Evercore ISI analyst Vijay Kumar lowered the price target on NovoCure Ltd. (NASDAQ: NVCR) to $14.50 (from $15.00) while maintaining a In Line rating.

The analyst comments "NVCR reported headline revs of $139 MM, up +13% y/y (vs -11% comp) with total revs coming in slightly above ST. Total revs incl ~$4.2 MM from prior period claims in U.S., ex which magnitude of the Beat was ~3%. Active patients and TRx both grew... More